Open AccessHyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: Where Do We Go From Here?
Author(s) -
Markman Maurie
Publication year - 2016
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2015-0486
Subject(s) - medicine , intraperitoneal chemotherapy , ovarian cancer , hyperthermic intraperitoneal chemotherapy , chemotherapy , oncology , intensive care medicine , cytoreductive surgery , cancer
The ongoing debate regarding a potential role for hyperthermic intraperitoneal chemotherapy in the management of ovarian cancer represents an excellent example of the rarely publicly discussed fundamental clash between the requirements of evidence‐based medicine and the roles of clinical innovation and optimization of care for the individual patient.